Ms. Maria Lukina
at Privolzhsky Research Medical Univ
SPIE Involvement:
Author
Publications (8)

PROCEEDINGS ARTICLE | February 23, 2018
Proc. SPIE. 10498, Multiphoton Microscopy in the Biomedical Sciences XVIII
KEYWORDS: Cancer, Tumors, Imaging systems, Skin, Microscopy, Luminescence, Melanoma, Fluorescence lifetime imaging, In vivo imaging, Mode conditioning cables

PROCEEDINGS ARTICLE | July 28, 2017
Proc. SPIE. 10411, Clinical and Preclinical Optical Diagnostics
KEYWORDS: Cancer, Microscopy, Fluorescence lifetime imaging, Mode conditioning cables

PROCEEDINGS ARTICLE | July 28, 2017
Proc. SPIE. 10413, Novel Biophotonics Techniques and Applications IV
KEYWORDS: Tumors, Fiber optics, Spectroscopy, Luminescence, Fluorescence spectroscopy, Single photon, Phosphorescence, Fluorescence lifetime imaging, Time resolved spectroscopy

PROCEEDINGS ARTICLE | March 2, 2017
Proc. SPIE. 10069, Multiphoton Microscopy in the Biomedical Sciences XVII
KEYWORDS: Second-harmonic generation, Oncology, Multiphoton microscopy, Tumor growth modeling, Cancer, Tumors, Tissues, Microscopy, Luminescence, Fluorescence lifetime imaging, In vivo imaging, Harmonic generation, Multiphoton fluorescence microscopy, In vitro testing, Mode conditioning cables

PROCEEDINGS ARTICLE | February 21, 2017
Proc. SPIE. 10069, Multiphoton Microscopy in the Biomedical Sciences XVII
KEYWORDS: Confocal microscopy, Oncology, Cancer, Sensors, Microscopy, Luminescence, Hydrogen, Cell death, Cytoskeletons, Fluorescence lifetime imaging, Fluorescent proteins, Two photon excitation microscopy, Mode conditioning cables

PROCEEDINGS ARTICLE | April 27, 2016
Proc. SPIE. 9887, Biophotonics: Photonic Solutions for Better Health Care V
KEYWORDS: Cancer, Tumors, Tissues, Microscopy, Luminescence, Acquisition tracking and pointing, Fluorescence lifetime imaging, In vivo imaging, In vitro testing, Mode conditioning cables

Showing 5 of 8 publications
SIGN IN TO:
  • View contact details

UPDATE YOUR PROFILE
Is this your profile? Update it now.
Don’t have a profile and want one?

Back to Top